La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Pharma Mar Gestione
Gestione criteri di controllo 1/4
Pharma Mar's Il CEO è Jose Fernandez Sousa-Faro, nominato in Jan1986, ha un mandato di 38.58 anni. possiede direttamente 6.35% delle azioni della società, per un valore di € 42.16M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 13.5 anni e 2.2 anni.
Informazioni chiave
Jose Fernandez Sousa-Faro
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 38.7yrs |
| Proprietà del CEO | 6.4% |
| Durata media del management | 13.5yrs |
| Durata media del Consiglio di amministrazione | 2.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Pharma Mar, S.A.'s (BME:PHM) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Jul 28
Pharma Mar (BME:PHM) Will Pay A Larger Dividend Than Last Year At €0.65
Jun 01Pharma Mar, S.A.'s (BME:PHM) Shares Bounce 29% But Its Business Still Trails The Industry
May 28Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 03Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Apr 28We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability
Mar 08Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)
Mar 05Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued
Sep 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%
May 04Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding
Mar 16Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly
Sep 08News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts
Aug 03Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock
May 31Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
May 10Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 08Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years
Jan 14Is Pharma Mar (BME:PHM) A Risky Investment?
Nov 19AMMINISTRATORE DELEGATO
Jose Fernandez Sousa-Faro
38.7yrs
Mandato
€294,000
Compensazione
Mr. José María Fernández Sousa-Faro, Ph D., founded Pharma Mar, S.A.U. in 1986. He Founded Noscira, S.A., in 2000.He serves as the Chief Executive Officer and President of Pharma Mar, S.A.U. He serves as...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | 38.7yrs | €294.00k | 6.35% € 45.5m | |
| Executive Vice-Chairman | no data | €124.00k | Nessun dato | |
| Founder | no data | Nessun dato | Nessun dato | |
| Chief Financial Officer | 24.7yrs | Nessun dato | Nessun dato | |
| Head of Capital Markets & Investor Relations | 9.7yrs | Nessun dato | Nessun dato | |
| General Counsel & Secretary of the Board of Directors | 5yrs | Nessun dato | Nessun dato | |
| Global Compliance Head | 4.3yrs | Nessun dato | Nessun dato | |
| Communication Director | no data | Nessun dato | Nessun dato | |
| Director of Corporate Development | 2.7yrs | Nessun dato | Nessun dato | |
| Director of Human Resources & IT | 21.2yrs | Nessun dato | Nessun dato | |
| Managing Director of Oncology & Virology Business Units | 17.4yrs | Nessun dato | Nessun dato | |
| Chief Operating Officer of Pharmar U.S. | no data | Nessun dato | Nessun dato |
13.5yrs
Durata media
Gestione esperta: Il team dirigenziale di PHM è esperto e expertise (durata media dell'incarico 13.5 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | no data | €294.00k | 6.35% € 45.5m | |
| Executive Vice-Chairman | no data | €124.00k | Nessun dato | |
| Independent Other External Director | 3.7yrs | €35.00k | 0.063% € 449.3k | |
| Independent Other External Director | no data | €35.00k | Nessun dato | |
| Proprietary Director | no data | €34.00k | 5.44% € 38.9m | |
| Independent Director | 5.7yrs | Nessun dato | Nessun dato | |
| Representative Proprietary Director | 3.8yrs | Nessun dato | Nessun dato | |
| Independent Director | 2.3yrs | Nessun dato | 0.0010% € 7.5k | |
| Independent Coordinating Director | 2.3yrs | Nessun dato | Nessun dato | |
| Independent Director | 2.3yrs | Nessun dato | Nessun dato | |
| Independent Other External Director | no data | Nessun dato | Nessun dato | |
| Independent Director | 1.3yrs | Nessun dato | Nessun dato |
2.3yrs
Durata media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di PHM non è considerato esperto (durata media del mandato 2.2 anni), il che suggerisce un nuovo consiglio.